Table 2.
Clinical features of patients with CHM
| Characteristic (n=94) | No | (%) |
| Amenorrhea | 76 | (80.9) |
| Vaginal bleeding | 21 | (22.3) |
| Hyperemesis gravidarum | 14 | (14.9) |
| Haemoptysis | 3 | (3.2) |
| Theca lutein cysts | 31 | (32.7) |
| Pulmonary metastasis | 14 | (14.9) |
| Cerebral metastases | 3 | (3.2) |
| Hepatic metastases | 3 | (3.2) |
| Genital extra-uterine metastases | 5 | (5.3) |
| Uterus greater than dates | 62 | (66.3) |
| Hypertension | 38 | (40.4) |
| Hyperthyroidism | 4 | (4.3) |
| Spontaneous remission | 5 | (5.3) |
| Required other chemotherapy | 4 | (4.3) |
| Deaths due GTD | 8 | (8.6) |
The majority of patients presented with vaginal bleeding. Presence of extra-uterine metastases indicates a diagnosis of Malignant metastatic GTD or Choriocarcinoma. None of the patients continued to have vaginal bleeding after evacuation.